POS0941 INTENSIVE REDUCTION OF SERUM URIC ACID WITH URICASE EFFECT THROUGH THE COMBINATION OF BENZBR...
POS0941 INTENSIVE REDUCTION OF SERUM URIC ACID WITH URICASE EFFECT THROUGH THE COMBINATION OF BENZBROMARONE AND FEBUXOSTAT IN PATIENTS WITH DIFFICULT-TO-TREAT TOPHACEOUS GOUT
About this item
Full title
Author / Creator
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Subjects
More information
Scope and Contents
Contents
Background:Some patients with gout have multiple comorbidities and subcutaneous tophi refractory to conventional monotherapy with urate-lowering treatments (ULT). Uricases may be helpful drugs, but they are not always available. Combined treatment with two potent ULT, such as FBX and BNZ, could achieve a uricase-like effect and be a therapeutic alt...
Alternative Titles
Full title
POS0941 INTENSIVE REDUCTION OF SERUM URIC ACID WITH URICASE EFFECT THROUGH THE COMBINATION OF BENZBROMARONE AND FEBUXOSTAT IN PATIENTS WITH DIFFICULT-TO-TREAT TOPHACEOUS GOUT
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3068475395
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3068475395
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2024-eular.5897
